Literature DB >> 20717002

Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists.

Ankur R Sangoi1, Andrew H Beck, Mahul B Amin, Liang Cheng, Jonathan I Epstein, Donna E Hansel, Kenneth A Iczkowski, Antonio Lopez-Beltran, Esther Oliva, Gladell P Paner, Victor E Reuter, Jae Y Ro, Rajal B Shah, Steven S Shen, Pheroze Tamboli, Jesse K McKenney.   

Abstract

Invasive micropapillary carcinoma (IMPC) of the urinary tract is a well-described variant of the urothelial carcinoma with aggressive clinical behavior. Recent studies have proposed that patients with IMPC on transurethral resection should be treated with radical cystectomy regardless of the pathologic stage. Despite the potentially important therapeutic implications of this diagnosis, interobserver variation in the diagnosis of IMPC has not been studied. Sixty digital images, each from hematoxylin and eosin-stained slides, representing 30 invasive urothelial carcinomas (2 images per case), were distributed to 14 genitourinary subspecialists and each pathologist was requested to classify cases as IMPC or not. These cases included "classic" IMPC (n=10) and urothelial carcinoma with retraction and variably sized nests that might potentially be regarded as IMPC (n=20). The following 13 morphologic features were recorded as positive/negative for all cases independent of the reviewers' diagnoses: columnar cells, elongate nests or processes, extensive stromal retraction, lumen formation with internal epithelial tufting, epithelial ring forms, intracytoplasmic vacuolization, multiple nests within the same lacunar space, back-to-back lacunar spaces, epithelial nest anastomosis/confluence, marked nuclear pleomorphism, peripherally oriented nuclei, randomly distributed nuclei, and tumor nest size. In addition, a mean tumor nest size was calculated for each image based on the number of nuclei spanning the width of the nests. Interobserver reproducibility was assessed and the morphologic features were correlated with the classic IMPC and nonclassic/potential IMPC groups. In addition, the relationships between morphologic features, pathologists' interpretations, and case type (classic IMPC vs. nonclassic/potential IMPC) were evaluated using unsupervised hierarchical clustering analysis. Interobserver reproducibility for a diagnosis of IMPC in the 30 study cases was moderate (kappa: 0.54). Although classification as IMPC among the 10 "classic" IMPC cases was relatively uniform (93% agreement), the classification in the subset of 20 invasive urothelial carcinomas with extensive retraction and varying sized tumor nests was more variable. Multiple nests within the same lacunar space had the highest association with a diagnosis of classic IMPC. These findings suggest that more study of IMPC is needed to identify the individual pathologic features that might potentially correlate with an aggressive outcome and response to intravesical therapy.

Entities:  

Mesh:

Year:  2010        PMID: 20717002     DOI: 10.1097/PAS.0b013e3181ec86b3

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  27 in total

1.  Stromal micropapillary pattern predominant lung adenocarcinoma--a report of two cases.

Authors:  Miki Ohe; Tomoyuki Yokose; Yuji Sakuma; Sachie Osanai; Chikako Hasegawa; Kota Washimi; Kimitoshi Nawa; Tetsukan Woo; Rurika Hamanaka; Haruhiko Nakayama; Yoichi Kameda; Kouzo Yamada; Takeshi Isobe
Journal:  Diagn Pathol       Date:  2011-09-29       Impact factor: 2.644

2.  Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy.

Authors:  Simone Bertz; S Wach; H Taubert; R Merten; F S Krause; S Schick; O J Ott; E Weigert; O Dworak; C Rödel; R Fietkau; B Wullich; B Keck; A Hartmann
Journal:  Virchows Arch       Date:  2016-07-08       Impact factor: 4.064

3.  SIU-ICUD on bladder cancer: pathology.

Authors:  Eva Compérat; Marek Babjuk; Ferran Algaba; Mahul Amin; Fadi Brimo; David Grignon; Donna Hansel; Ondra Hes; Bernard Malavaud; Victor Reuter; Theo van der Kwast
Journal:  World J Urol       Date:  2018-09-14       Impact factor: 4.226

4.  Canadian Urological Association guideline: Muscle-invasive bladder cancer.

Authors:  Girish S Kulkarni; Peter C Black; Srikala S Sridhar; Anil Kapoor; Alexandre R Zlotta; Bobby Shayegan; Ricardo A Rendon; Peter Chung; Theodorus van der Kwast; Nimira Alimohamed; Yves Fradet; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2019-01-31       Impact factor: 1.862

5.  Micropapillary Bladder Cancer Metastatic to the Breast: A Case Report and Brief Literature Review.

Authors:  Elena Lievore; Letterio Runza; Michele Ghidini; Barbara Galassi; Andrea Gallioli; Carolina Bebi; Luca Boeri; Concetta Blundo; Claudia Francesca Rossi; Fabrizio Longo; Giancarlo Albo; Emanuele Montanari; Elisa DE Lorenzis
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

6.  Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.

Authors:  Massimiliano Spaliviero; Guido Dalbagni; Bernard H Bochner; Bing Ying Poon; Hongying Huang; Hikmat A Al-Ahmadie; Timothy F Donahue; Jennifer M Taylor; Joshua J Meeks; Daniel D Sjoberg; S Machele Donat; Victor E Reuter; Harry W Herr
Journal:  J Urol       Date:  2014-03-03       Impact factor: 7.450

7.  FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma.

Authors:  Joshua I Warrick; Matthew Kaag; Jay D Raman; Wilson Chan; Truc Tran; Sudhir Kunchala; Lauren Shuman; David DeGraff; Guoli Chen
Journal:  Virchows Arch       Date:  2017-07-18       Impact factor: 4.064

8.  High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.

Authors:  Doreen Nguyen; Diana Taheri; Simeon Springer; Morgan Cowan; Gunes Guner; Maria Angelica Mendoza Rodriguez; Yuxuan Wang; Isaac Kinde; Christopher J VandenBussche; Matthew T Olson; Bernardo F P Ricardo; Isabela Cunha; Kazutoshi Fujita; Dilek Ertoy; Kenneth W Kinzler; Trinity J Bivalacqua; Nickolas Papadopoulos; Bert Vogelstein; George J Netto
Journal:  Virchows Arch       Date:  2016-08-12       Impact factor: 4.064

Review 9.  Micropapillary bladder cancer: current treatment patterns and review of the literature.

Authors:  Daniel L Willis; Thomas W Flaig; Donna E Hansel; Matthew I Milowsky; Robert L Grubb; Hikmat A Al-Ahmadie; Elizabeth R Plimack; Theresa M Koppie; David J McConkey; Colin P Dinney; Vanessa A Hoffman; Michael J Droller; Edward Messing; Ashish M Kamat
Journal:  Urol Oncol       Date:  2014-06-13       Impact factor: 3.498

10.  Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy.

Authors:  Alexandra Masson-Lecomte; Evanguelos Xylinas; Morgane Bouquot; Mathilde Sibony; Yves Allory; Eva Comperat; Marc Zerbib; Alexandre de la Taille; Morgan Rouprêt
Journal:  World J Urol       Date:  2014-09-02       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.